Association of PM2.5 exposure with 10-year atherosclerotic cardiovascular disease risk: a mediation analysis of blood and urinary biomarkers

PM2.5暴露与10年动脉粥样硬化性心血管疾病风险的关联:血液和尿液生物标志物的中介分析

阅读:1

Abstract

AIMS: To explore the relationship of fine particulate matter (PM(2.5)) exposure with 10-year risk of atherosclerotic cardiovascular disease (ASCVD), explore effect modifiers, identify susceptible populations, and examine potential mediating factors. METHODS AND RESULTS: A cross-sectional study among 9,539 residents of Fujian Province, China, from May 2021 to January 2022 was administered. PM(2.5) exposure was estimated using the China High Air Pollutants (CHAP) dataset with a spatial resolution of 1 km from May 2021 to January 2022. ASCVD risk was predicted utilizing the China-PAR model. We performed weighted linear mixed-effects models to assess the association of exposure to PM(2.5) with 10-year risk of ASCVD. Potential effect modifiers were assessed using stratified analyses and interaction analysis. We used mediation analyses to explore the role of blood and urine indicators in this association. An elevated risk of 10-year ASCVD was found in association with PM(2.5) exposure. For every 5 μg/m(3) rise in PM(2.5), 10-year ASCVD risk increased by 3.246 (95% CI: 2.602, 3.889). Age, smoking, alcohol consumption, and hypertension modified the association of exposure to PM(2.5) with the risk of ASCVD. Glycosylated hemoglobin, fasting blood glucose, and blood uric acid partially mediated this association. CONCLUSION: Exposure to PM(2.5) is correlated with the elevated 10-year ASCVD risk, with blood glucose, and uric acid potentially acting as mediators.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。